June 10, 2024

Intragastric Balloon Market Size to Rake USD 108.80 Mn by 2033

The global intragastric balloon market size was estimated at USD 45 million in 2023 and is projected to attain around USD 108.80 million by 2033, expanding at a CAGR of 9.22% from 2024 to 2033.

Key Points

  • By region, North America held the largest share of the intragastric balloon market in 2023 with 38.4%.
  • By region, Asia Pacific is expected to witness significant growth during the forecast period.
  • By balloon type, in 2023, the single segment held the largest share of 66%.
  • By filling material, the saline filled segment held the dominant share of around 73% in 2023.
  • By administration, the endoscopy segment held the largest share of over 72.3% in 2023.
  • By end use, the hospitals segment has accounted market share of around 55% in 2023.

Intragastric Balloon Market Size 2024 to 2033

The intragastric balloon market is a rapidly growing sector within the medical device industry, primarily driven by the increasing prevalence of obesity and related health issues across the globe. Intragastric balloons are minimally invasive, temporary devices placed inside the stomach to aid in weight loss. These devices work by occupying space in the stomach, which limits food intake and promotes a feeling of fullness. Over time, this leads to a reduction in body weight, particularly when combined with lifestyle modifications such as diet and exercise.

The intragastric balloon market has witnessed significant growth over the last decade, with several factors contributing to its expansion. These include a growing awareness of obesity-related health risks, advancements in minimally invasive medical technologies, and increased adoption of intragastric balloons as an alternative to bariatric surgery.

Get a Sample: https://www.precedenceresearch.com/sample/4081

Growth Factors

  1. Rising Obesity Rates: Obesity rates have been on the rise worldwide, leading to an increase in demand for weight loss solutions. As a result, there is a growing market for intragastric balloons as a non-surgical alternative to treat obesity.
  2. Technological Advancements: Continuous improvements in intragastric balloon design and implantation techniques have made the procedure safer and more effective, attracting more patients and healthcare providers.
  3. Increasing Healthcare Expenditure: With growing healthcare budgets in many countries, governments and private insurers are more willing to cover weight loss treatments, including intragastric balloon procedures.
  4. Awareness and Accessibility: Increased awareness about obesity and its associated health risks, coupled with easier access to medical treatments, has contributed to the growing popularity of intragastric balloons.
  5. Minimally Invasive Procedures: Patients and healthcare providers are increasingly favoring minimally invasive procedures over traditional surgeries due to shorter recovery times, fewer complications, and lower costs.

Region Insights

The intragastric balloon market can be segmented into several key regions:

  1. North America: This region dominates the market due to its high obesity rates, advanced healthcare infrastructure, and increased adoption of weight loss treatments. The United States leads the market in this region.
  2. Europe: Europe also has a strong market presence, with several countries showing a high prevalence of obesity. Countries such as the United Kingdom, Germany, and France have seen a rise in intragastric balloon procedures.
  3. Asia-Pacific: The Asia-Pacific region is expected to experience significant growth in the coming years due to rising obesity rates, a growing middle class, and increasing healthcare investments. Countries like China and India offer significant market potential.
  4. Latin America: This region is also seeing growth in the intragastric balloon market due to increasing obesity rates and improvements in healthcare infrastructure, particularly in countries such as Brazil and Mexico.
  5. Middle East and Africa: While the market in this region is still emerging, there is potential for growth due to rising obesity rates and increased awareness of weight loss treatments.

Intragastric Balloon Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 9.22%
Global Market Size in 2023 USD 45 Million
Global Market Size in 2024 USD 49.15 Million
Global Market Size by 2033 USD 108.8 Million
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Balloon Type, By Filling Material, By Administration, and By End-use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Intragastric Balloon Market Dynamics


  1. Increasing Obesity and Related Health Issues: As obesity rates continue to rise globally, there is a growing demand for effective weight loss solutions, such as intragastric balloons.
  2. Non-Surgical Weight Loss Option: Intragastric balloons offer a minimally invasive alternative to traditional bariatric surgeries, making them an attractive option for patients seeking weight loss solutions.
  3. Short Procedure Time and Recovery Period: The intragastric balloon procedure is relatively quick and requires a shorter recovery period compared to other weight loss surgeries, appealing to both patients and healthcare providers.
  4. Growing Acceptance and Awareness: Increased awareness of the benefits of intragastric balloons, both among patients and healthcare professionals, has led to wider acceptance and adoption of this treatment option.


  1. Product Development and Innovation: There is significant potential for the development of new intragastric balloon devices with improved safety and efficacy. Innovations in materials, design, and implantation techniques can drive market growth.
  2. Expansion into Emerging Markets: Expanding the availability of intragastric balloon treatments into emerging markets, such as Africa and Southeast Asia, can provide opportunities for market growth.
  3. Strategic Partnerships and Collaborations: Partnerships with healthcare providers, hospitals, and clinics can help expand the market reach and increase the adoption of intragastric balloon treatments.
  4. Telemedicine and Remote Monitoring: Leveraging telemedicine and remote monitoring technologies can improve patient outcomes and provide ongoing support to patients undergoing intragastric balloon treatments.
  5. Regulatory Approvals and Certifications: Obtaining regulatory approvals and certifications in various regions can open up new markets and drive growth.


  1. Potential Complications: Although intragastric balloon procedures are generally safe, there are potential complications such as balloon deflation, migration, and perforation, which may deter some patients.
  2. Limited Long-Term Data: There is still limited long-term data on the effectiveness and safety of intragastric balloons, which may impact their adoption and use.
  3. Cost Concerns: The cost of intragastric balloon procedures can be high, particularly in regions with limited healthcare coverage. This may limit access for some patients.
  4. Reimbursement and Insurance Issues: Variability in insurance coverage and reimbursement policies can impact the adoption of intragastric balloon treatments, particularly in markets where these procedures are not widely covered.
  5. Competition from Other Weight Loss Treatments: There are various other weight loss treatments available, such as bariatric surgery and pharmacological options, which may compete with intragastric balloon procedures.

Read Also: Cellular Health Screening Market Size, Share, Report by 2033

Recent Developments

  • In September 2022, Allurion Technologies, the United States-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India.

Intragastric Balloon Market Companies

  • Allurion Technologies
  • Allergan (Acquired by Abbott)
  • Apollo Endosurgery
  • Reshape Medical
  • Spatz FGIA
  • Endalis
  • Silimed
  • Medsil

Segment Covered in the Report

By Balloon Type

  • Single
  • Dual
  • Triple

By Filling Material

  • Saline Filled
  • Gas Filled

By Administration

  • Endoscopy
  • Pill Form

By End-use

  • Hospitals
  • Ambulatory Centers

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/



I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *